v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
OPERATING ACTIVITIES:    
Net loss $ (13,254) $ (11,284)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 36 33
Non-cash lease expense 107 116
Non-cash interest expense 251 0
Amortization of debt issuance costs 141 0
Stock-based compensation 2,128 1,846
Common stock issued to consultant for services rendered 0 60
Restricted stock units released to consultant for services rendered 0 29
Change in fair value of liability classified instruments (1,531) (33)
Loss on extinguishment of financial commitment assets and contingent warrants, net 1,616 0
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (664) 50
Accounts payable (71) 963
Accrued expenses 113 (115)
Operating lease liabilities (107) (105)
Increase (Decrease) in Other Current Liabilities (17) 368
Net cash used in operating activities (11,252) (8,072)
INVESTING ACTIVITIES:    
Purchase of equipment (53) (46)
Net cash used in investing activities (53) (46)
FINANCING ACTIVITIES:    
Proceeds from the exercise of stock options 9 2
Proceeds from issuance of Series A convertible preferred stock, net 0 4,940
Net cash provided by financing activities 31,259 10,487
Effect of foreign currency on cash 14 0
NET INCREASE IN CASH AND CASH EQUIVALENTS 19,968 2,369
CASH AND CASH EQUIVALENTS:    
At beginning of the period 3,056 3,672
At end of the period 23,024 6,041
SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING AND INVESTING ACTIVITIES:    
Transfer of right‑of‑use assets to property and equipment upon title transfer 0 75
Initial recognition of Tranche Liability 3,282 0
Settlement of Tranche Liability 1,905 0
Deemed dividend on down round provision from Series A Convertible Preferred Stock 2,539 0
Conversion of Preferred Series A stock into common stock 4,940 0
Juvenescence    
FINANCING ACTIVITIES:    
Proceeds from issuance of common stock 0 4,916
At The Market Sales Agreement    
FINANCING ACTIVITIES:    
Proceeds from issuance of common stock 10,169 629
Private Placement    
FINANCING ACTIVITIES:    
Proceeds from issuance of common stock and warrants in connection with private placement, net $ 21,081 $ 0